- Home
- PRAX vs GRNT Comparison
PRAX vs GRNT Comparison
Compare PRAX & GRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- GRNT
- Stock Information
- Founded
- PRAX 2015
- GRNT 2013
- Country
- PRAX United States
- GRNT United States
- Employees
- PRAX N/A
- GRNT N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- GRNT Blank Checks
- Sector
- PRAX Health Care
- GRNT Finance
- Exchange
- PRAX Nasdaq
- GRNT Nasdaq
- Market Cap
- PRAX 599.7M
- GRNT 647.8M
- IPO Year
- PRAX 2020
- GRNT N/A
- Fundamental
- Price
- PRAX $38.35
- GRNT $5.19
- Analyst Decision
- PRAX Strong Buy
- GRNT Buy
- Analyst Count
- PRAX 10
- GRNT 4
- Target Price
- PRAX $116.50
- GRNT $7.70
- AVG Volume (30 Days)
- PRAX 430.8K
- GRNT 403.3K
- Earning Date
- PRAX 05-02-2025
- GRNT 05-08-2025
- Dividend Yield
- PRAX N/A
- GRNT 8.49%
- EPS Growth
- PRAX N/A
- GRNT N/A
- EPS
- PRAX N/A
- GRNT 0.09
- Revenue
- PRAX $8,122,000.00
- GRNT $392,965,000.00
- Revenue This Year
- PRAX N/A
- GRNT $33.06
- Revenue Next Year
- PRAX $789.73
- GRNT $10.17
- P/E Ratio
- PRAX N/A
- GRNT $57.48
- Revenue Growth
- PRAX 270.02
- GRNT 5.65
- 52 Week Low
- PRAX $26.70
- GRNT $4.52
- 52 Week High
- PRAX $91.83
- GRNT $7.10
- Technical
- Relative Strength Index (RSI)
- PRAX 53.31
- GRNT 52.52
- Support Level
- PRAX $34.89
- GRNT $4.88
- Resistance Level
- PRAX $40.89
- GRNT $5.11
- Average True Range (ATR)
- PRAX 2.30
- GRNT 0.14
- MACD
- PRAX 0.70
- GRNT 0.07
- Stochastic Oscillator
- PRAX 57.95
- GRNT 92.44
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About GRNT Granite Ridge Resources Inc.
Granite Ridge Resources Inc is a scaled, non-operated oil and gas exploration and production company. It invests in a diversified portfolio of production and top-tier acreage across the Permian and other prolific U.S. basins in partnership with operators. It generates maximum revenue from Oil.